Showing 541-550 of 1378 results for "".
- skinbetter science® Launches Even Intensive Skin Tone Correcting Serumhttps://modernaesthetics.com/news/skinbetter-science-launches-even-intensive-skin-tone-correcting-serum/2475366/skinbetter science® has announced the launch Even Intensive Skin Tone Correcting Serum, an advanced discoloration treatment formulated to address persistent dark marks, uneven tone, and skin texture irregularities. A
- Johnson & Johnson MedTech Launches Larger-Sized Breast Implants for Post-Mastectomy Reconstructionhttps://modernaesthetics.com/news/johnson-johnson-medtech-launches-larger-sized-breast-implants-for-post-mastectomy-reconstruction/2475365/Johnson & Johnson MedTech has announced the U.S. launch of MENTORTM Memory GelTM Enhanced Breast Implants, a new line of breast implants specifically developed for women undergoing primary or revision reconstruction after mastectomy. The implants, which received FDA appr
- Teoxane Launches Consumer Access to Dermocosmetic Skincare Line in U.S.https://modernaesthetics.com/news/teoxane-launches-consumer-access-to-dermocosmetic-skincare-line-in-us/2475362/Teoxane has announced the U.S. launch of its dermocosmetics line, making its clinically developed skincare products available directly to consumers for the first time through its new online platform, teoxane.us. Previously offered exclusively through aesthetic professionals, the Swiss c
- ASLMS 2025: E. Victor Ross, MD, Talks Landscape of Fractional Laser Treatmentshttps://modernaesthetics.com/news/aslms-2025-e-victor-ross-md-talks-landscape-of-fractional-laser-treatments/2475359/At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, E. Victor Ross, MD, shared insights on the evolving role of fractional lasers in dermatologic practice, highlighting both their advantages and limitations. Risk, Recovery, and Pigmenta
- ASLMS 2025: New Laser Platforms Expand Options for Vascular Rosaceahttps://modernaesthetics.com/news/aslms-2025-new-laser-platforms-expand-options-for-vascular-rosacea/2475358/Advanced vascular lasers are transforming the treatment of rosacea by targeting its root cause (chronic vascular dilation) rather than just managing inflammation. At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, Eric Bernstein, MD, Director
- Bausch Health Launches Fraxel FTX™ at ASLMS 2025https://modernaesthetics.com/news/bausch-health-launches-fraxel-ftx-at-aslms-2025/2475353/Bausch Health Companies Inc. and its aesthetics division, Solta Medical, have introduced Fraxel FTX™, the latest advancement in laser skin resurfacing, at the American Society for Laser Medicine & Surgery (ASLMS) 2025 Annual Conference in Orlando, FL. The launch marks the beginning of a
- Candela Launches Dual-Wavelength Vbeam Pro for Vascular and Dermatologic Conditionshttps://modernaesthetics.com/news/candela-launches-dual-wavelength-vbeam-pro-for-vascular-and-dermatologic-conditions/2475352/Candela has introduced its latest pulsed dye laser platform, the Vbeam Pro, at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) in Orlando, Florida.
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum to
- Clinical Data on Lumenis’ New Laser Hair Removal Solution to Be Presented at ASLMS Conferencehttps://modernaesthetics.com/news/new-data-on-lumenis-new-laser-hair-removal-solution-to-be-presented-at-aslms-conference/2475349/Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X
- Evolus Launches “Drop the F Word” Campaign Ahead of Evolysse Injectable HA Gelshttps://modernaesthetics.com/news/evolus-launches-drop-the-f-word-campaign-ahead-of-evolysse-injectable-ha-gels/2475348/Evolus, Inc. rolled out a new campaign, “Drop the F Word,” ahead of the upcoming commercial launch of EvolysseTM injectable hyaluronic acid gels. The campaign aims to challenge outdated perceptions and language in the aesthetics industry, according to a press release,